INFANS - Integrating Functional Assessment measures for Neonatal Safeguard
“INFANS - INtegrating Functional Assessment measures for Neonatal Safeguard" is a part of the Marie Skłodowska-Curie Innovative Training Network funded by the European Union’s Horizon 2020 Research and Innovation Programme.
The goal of INFANS is to develop a new neonatal brain monitoring, designed to overcome the severe shortage of clinically viable means to high quality monitor the brain function in infancy, crucial to prevent later life neurological, cognitive and motor impairment. To accomplish this goal, INFANS established a structured European PhD training programme in biomedical engineering, signal processing and clinical procedures to train a new generation of creative and entrepreneurial young researchers.
The individual research projects of the ESR encompass the topics technological innovation, industrial development, clinical validation, identification of neonatal healthcare needs. As part of their research the INFANS ESRs will develop a novel platform for high quality, clinically-viable EEG-NIRS monitoring accessible worldwide. Well-targeted visits and secondments, soft skills and dynamic training activities, an Open Science strategy, extensive involvement of ESRs in the network events organization, extensive contacts with other research, training and industrial European networks, dissemination activities and the award of Double doctoral degrees are further assets offered to INFANS ESRs.
Excellent science, industrial leadership and societal challenge are merged in the INFANS network. The INFANS consortium includes 6 academic and 4 non-academic partners from 6 EU countries, among which leading universities, companies and clinical institutions. The partners involved in INFANS share complementary expertise and facilities to provide international, interdisciplinary and intersectoral research training and mobility that will complement local doctoral training. The INFANS ESRs will become independent researchers with improved career prospects in both the academic and non-academic sectors, and will advance the EU capacity for innovation in biomedical engineering.